Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia
Clinical trial NCT05066165 · TERMINATED
Trial details
- NCT number
- NCT05066165
- Sponsor
- Intellia Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2022-07-21
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.